Clinical Trial Update: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis

View source ↗

Summary

This clinical trial update reports on the immunogenicity of a combined anti-pneumococcal vaccine schedule in patients with ANCA-associated vasculitis; the curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Pneumococcal Infection

Drugs mentioned

• Pneumococcal vaccines (combined schedule)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumococcal Infection, ANCA-associated Vasculitis | Status: UNKNOWN